- Advertisement -

Boost For Inflammatory Disease Biotech NodThera With €49M Series B

The UK-US biotech NodThera has raised €48.7M in Series B funding to progress its drug candidate through clinical trials for the treatment of inflammatory...

Illinois team develops first of a kind in-vitro 3D neural tissue model

Credit: University of Illinois Department of Bioengineering Researchers at the University of Illinois at Urbana-Champaign have successfully...

Unity Biotechnology, Inc. (NASDAQ:UBX) Short Interest Update – MarketBeat

Unity Biotechnology, Inc. (NASDAQ:UBX) was the recipient of a large increase in short interest during the month of January. As of January 15th, there...

Genetic testing: A game-changer for healthcare

As genetic sequencing technology becomes more accessible and efficient, researchers have made significant strides in understanding the genetic underpinnings of various diseases. This knowledge...

Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short … – MarketBeat

Global X Genomics & Biotechnology ETF (NASDAQ:GNOM - Get Rating) was the recipient of a large increase in short interest during the month of...

Small-Molecule “Unsilencers” Show Promise against Angelman Syndrome

Angelman syndrome (AS) is a rare genetic disorder characterized by poor muscle control, limited speech, epilepsy, and intellectual disabilities. There is no cure for...

Protein Protects Against Tau Tangles, Synaptic Loss in Mouse Model of...

Alzheimer’s disease (AD) and many other forms of neurodegeneration share a common culprit. In these diseases, tau proteins that normally stabilize neuronal microtubule filaments...

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the brain....

Protein Protects Against Tau Tangles, Synaptic Loss in Mouse Model of Tauopathy

Alzheimer’s disease (AD) and many other forms of neurodegeneration share a common culprit. In these diseases, tau proteins that normally stabilize neuronal microtubule filaments...

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the brain....

See, Blind Mice: Consortium’s Drugs Restore Sight

A consortium led by scientists at the Institute for Bioengineering of Catalonia (IBEC) has developed a series of light-activated small molecule drugs that in...

more new items

Protein Protects Against Tau Tangles, Synaptic Loss in Mouse Model of...

Alzheimer’s disease (AD) and many other forms of neurodegeneration share a common culprit. In these diseases, tau proteins that normally stabilize neuronal microtubule filaments...

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the brain....

See, Blind Mice: Consortium’s Drugs Restore Sight

A consortium led by scientists at the Institute for Bioengineering of Catalonia (IBEC) has developed a series of light-activated small molecule drugs that in...